참고문헌 (153)

1. Cleve. Clin. J. Med. BF Mandell 77 151 2010 10.3949/ccjm/77a/03001 Mandell, B. F. Vaccination: an option not to be ignored. Cleve. Clin. J. Med. 77, 151 (2010). 

   상세보기

2. Clin. Infect. Dis. SA Plotkin 47 401 2008 10.1086/589862 Plotkin, S. A. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409 (2008). 

   상세보기

3. Curr. Opin. Rheumatol. Z Touma 25 164 2013 10.1097/BOR.0b013e32835d2b7b Touma, Z., Gladman, D. D. & Urowitz, M. B. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign. Curr. Opin. Rheumatol. 25, 164-170 (2013). 

   상세보기

4. Autoimmun. Rev. G Murdaca 13 75 2014 10.1016/j.autrev.2013.07.007 Murdaca, G. et al. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun. Rev. 13, 75-84 (2014). 

   상세보기

5. Autoimmun. Rev. S Van Assen 10 341 2011 10.1016/j.autrev.2010.12.003 Van Assen, S. et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun. Rev. 10, 341-352 (2011). 

   상세보기

6. Aging Dis. PJ Hohensinner 2 524 2011 Hohensinner, P. J., Goronzy, J. J. & Weyand, C. M. Telomere dysfunction, autoimmunity and aging. Aging Dis. 2, 524-537 (2011). 

7. Nat. Rev. Immunol. MR Stampfli 9 377 2009 10.1038/nri2530 Stampfli, M. R. & Anderson, G. P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat. Rev. Immunol. 9, 377-384 (2009). 

   상세보기

8. Rheumatology (Oxford) J Listing 52 53 2013 10.1093/rheumatology/kes305 Listing, J., Gerhold, K. & Zink, A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford) 52, 53-61 (2013). 

   상세보기

9. 10.1186/1479-5876-12-77 Germano, V. et al. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists. J. Transl. Med. http://dx.doi.org/10.1186/1479-5876-12-77 . 

   상세보기

10. Best Pract. Res. Clin. Rheumatol. S Sciascia 27 377 2013 10.1016/j.berh.2013.07.002 Sciascia, S., Cuadrado, M. J. & Karim, M. Y. Management of infection in systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 27, 377-389 (2013). 

    상세보기

11. Arthritis Care Res. (Hoboken) JR Curtis 66 990 2014 10.1002/acr.22281 Curtis, J. R. et al. Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. Arthritis Care Res. (Hoboken) 66, 990-997 (2014). 

    상세보기

12. Arthritis Res. Ther. G Ruiz-Irastorza 11 R109 2009 10.1186/ar2764 Ruiz-Irastorza, G. et al. Predictors of major infections in systemic lupus erythematosus. Arthritis Res. Ther. 11, R109 (2009). 

    상세보기

13. Arch. Intern. Med. KL Nichol 158 1769 1998 10.1001/archinte.158.16.1769 Nichol, K. L., Wuorenma, J. & von Sternberg, T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch. Intern. Med. 158, 1769-1776 (1998). 

    상세보기

14. Clin. Infect. Dis. E Hak 35 370 2002 10.1086/341403 Hak, E. et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin. Infect. Dis. 35, 370-377 (2002). 

    상세보기

15. BMC Musculoskelet. Disord. WA Blumentals 13 158 2012 10.1186/1471-2474-13-158 Blumentals, W. A., Arreglado, A., Napalkov, P. & Toovey, S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet. Disord. 13, 158 (2012). 

    상세보기

16. J. Epidemiol. Community Health CJ Wotton 66 1177 2012 10.1136/jech-2011-200168 Wotton, C. J. & Goldacre, M. J. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J. Epidemiol. Community Health 66, 1177-1181 (2012). 

    상세보기

17. Arthritis Rheum. AM Yee 40 1180 1997 10.1002/art.1780400626 Yee, A. M., Ng, S. C., Sobel, R. E. & Salmon, J. E. FcγRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus. Arthritis Rheum. 40, 1180-1182 (1997). 

    상세보기

18. Arthritis Rheum. JH Klippel 22 1321 1979 10.1002/art.1780221201 Klippel, J. H. et al. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum. 22, 1321-1325 (1979). 

    상세보기

19. Lupus C Naveau 14 903 2005 10.1191/0961203305lu2242xx Naveau, C. & Houssiau, F. A. Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 14, 903-906 (2005). 

    상세보기

20. Arthritis Rheum. TY Lu 61 482 2009 10.1002/art.24341 Lu, T. Y. et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthritis Rheum. 61, 482-487 (2009). 

    상세보기

21. Autoimmun. Rev. EG Favalli 8 266 2009 10.1016/j.autrev.2008.11.002 Favalli, E. G. et al. Serious infections during anti-TNFα treatment in rheumatoid arthritis patients. Autoimmun. Rev. 8, 266-273 (2009). 

    상세보기

22. JAMA A Strangfeld 301 737 2009 10.1001/jama.2009.146 Strangfeld, A. et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-α agents. JAMA 301, 737-744 (2009). 

    상세보기

23. Am. J. Med. MA Antonelli 90 295 1991 10.1016/0002-9343(91)90568-I Antonelli, M. A., Moreland, L. W. & Brick, J. E. Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am. J. Med. 90, 295-298 (1991). 

    상세보기

24. Clin. Infect. Dis. JR McDonald 48 1364 2009 10.1086/598331 McDonald, J. R. et al. Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin. Infect. Dis. 48, 1364-1371 (2009). 

    상세보기

25. Arthritis Rheum. AL Smitten 57 1431 2007 10.1002/art.23112 Smitten, A. L. et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 57, 1431-1438 (2007). 

    상세보기

26. Ann. Rheum. Dis. F Speerstra 41 Suppl. 1 37 1982 10.1136/ard.41.Suppl_1.37 Speerstra, F. et al. Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience. Ann. Rheum. Dis. 41, (Suppl. 1) 37-39 (1982). 

    상세보기

27. Rheumatology (Oxford) F Wolfe 45 1370 2006 10.1093/rheumatology/kel328 Wolfe, F., Michaud, K. & Chakravarty, E. F. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) 45, 1370-1375 (2006). 

    상세보기

28. Ann. Rheum. Dis. I Garcia-Doval 69 1751 2010 10.1136/ard.2009.125658 Garcia-Doval, I. et al. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann. Rheum. Dis. 69, 1751-1755 (2010). 

    상세보기

29. JAMA KL Winthrop 309 887 2013 10.1001/jama.2013.1099 Winthrop, K. L. et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA 309, 887-895 (2013). 

    상세보기

30. Ann. Rheum. Dis. S Ramiro 73 529 2014 10.1136/annrheumdis-2013-204575 Ramiro, S. et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann. Rheum. Dis. 73, 529-535 (2014). 

    상세보기

31. J. Rheumatol. LE Kahl 21 84 1994 Kahl, L. E. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J. Rheumatol. 21, 84-86 (1994). 

    상세보기

32. Rheumatol. Int. TY Kang 25 97 2005 10.1007/s00296-003-0403-3 Kang, T. Y., Lee, H. S., Kim, T. H., Jun, J. B. & Yoo, D. H. Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus. Rheumatol. Int. 25, 97-102 (2005). 

    상세보기

33. J. Rheumatol. S Manzi 22 1254 1995 Manzi, S. et al. Herpes zoster in systemic lupus erythematosus. J. Rheumatol. 22, 1254-1258 (1995). 

    상세보기

34. Lupus EF Chakravarty 22 238 2013 10.1177/0961203312470186 Chakravarty, E. F., Michaud, K., Katz, R. & Wolfe, F. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus 22, 238-244 (2013). 

    상세보기

35. Arthritis Rheum. E Ginzler 21 37 1978 10.1002/art.1780210107 Ginzler, E. et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 21, 37-44 (1978). 

    상세보기

36. Kansenshogaku Zasshi S Nagaoka 64 1394 1990 10.11150/kansenshogakuzasshi1970.64.1394 Nagaoka, S. et al. Herpes zoster in patients with polymyositis and dermatomyositis. Kansenshogaku Zasshi 64, 1394-1399 (1990). 

    상세보기

37. Ann. Rheum. Dis. K Nagasawa 49 630 1990 10.1136/ard.49.8.630 Nagasawa, K. et al. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann. Rheum. Dis. 49, 630-633 (1990). 

    상세보기

38. Singapore Med. J. F Wang 24 218 1983 Wang, F., Chua, C. T. & Bosco, J. Herpes zoster in patients with systemic lupus erythematosus. Singapore Med. J. 24, 218-220 (1983). 

    상세보기

39. JAMA EL Dubois 190 104 1964 10.1001/jama.1964.03070150014003 Dubois, E. L. & Tuffanelli, D. L. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190, 104-111 (1964). 

    상세보기

40. Clin. Exp. Dermatol. O Ishikawa 24 327 1999 10.1046/j.1365-2230.1999.00490.x Ishikawa, O., Abe, M. & Miyachi, Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin. Exp. Dermatol. 24, 327-328 (1999). 

    상세보기

41. J. Med. Assoc. Thai. S Janwityanuchit 76 542 1993 Janwityanuchit, S., Totemchokchyakarn, K., Krachangwongchai, K. & Vatanasuk, M. Infection in systemic lupus erythematosus. J. Med. Assoc. Thai. 76, 542-548 (1993). 

    상세보기

42. Arthritis Rheum. HM Moutsopoulos 21 798 1978 10.1002/art.1780210710 Moutsopoulos, H. M., Gallagher, J. D., Decker, J. L. & Steinberg, A. D. Herpes zoster in patients with systemic lupus erythematosus. Arthritis Rheum. 21, 798-802 (1978). 

    상세보기

43. J. Clin. Rheumatol. EF Borba 16 119 2010 10.1097/RHU.0b013e3181d52ed7 Borba, E. F. et al. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus. J. Clin. Rheumatol. 16, 119-122 (2010). 

    상세보기

44. Ann. Rheum. Dis. E Della-Torre 68 Suppl. 3 247 2009 Della-Torre, E. et al. Individualized therapy provides better outcome in patients with proliferative lupus nephritis: follow up of a cohort of Italian patients [abstract]. Ann. Rheum. Dis. 68 (Suppl. 3), 247 (2009). 

45. Ann. Rheum. Dis. M Tokunaga 66 470 2007 10.1136/ard.2006.057885 Tokunaga, M. et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann. Rheum. Dis. 66, 470-475 (2007). 

    상세보기

46. Rheumatology (Oxford) A Mak 48 944 2009 10.1093/rheumatology/kep120 Mak, A. et al. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression. Rheumatology (Oxford) 48, 944-952 (2009). 

    상세보기

47. Arthritis Rheum. JT Merrill 62 222 2010 10.1002/art.27233 Merrill, J. T. et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62, 222-233 (2010). 

    상세보기

48. Am. J. Med. PK Wung 118 1416 2005 10.1016/j.amjmed.2005.06.012 Wung, P. K. et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am. J. Med. 118, 1416 (2005). 

    상세보기

49. Arthritis Rheum. LS Tam 50 3619 2004 10.1002/art.20616 Tam, L. S., Chan, A. Y., Chan, P. K., Chang, A. R. & Li, E. K. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 50, 3619-3625 (2004). 

    상세보기

50. Arthritis Rheum. R Nath 57 619 2007 10.1002/art.22667 Nath, R. et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum. 57, 619-625 (2007). 

    상세보기

51. J. Korean Med. Sci. YH Lee 25 1431 2010 10.3346/jkms.2010.25.10.1431 Lee, Y. H. et al. Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus. J. Korean Med. Sci. 25, 1431-1437 (2010). 

    상세보기

52. J. Rheumatol. LS Tam 37 330 2010 10.3899/jrheum.090644 Tam, L. S. et al. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J. Rheumatol. 37, 330-340 (2010). 

    상세보기

53. Clin. Dev. Immunol. L Stojanovich 13 373 2006 10.1080/17402520600800820 Stojanovich, L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin. Dev. Immunol. 13, 373-375 (2006). 

    상세보기

54. Scand. J. Rheumatol. T Kobashigawa 42 445 2013 10.3109/03009742.2013.788733 Kobashigawa, T. et al. Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort. Scand. J. Rheumatol. 42, 445-450 (2013). 

    상세보기

55. Clin. Exp. Rheumatol. A Kostianovsky 30 1 Suppl. 70 S83 2012 Kostianovsky, A. et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clin. Exp. Rheumatol. 30 (1 Suppl. 70), S83-S89 (2012). 

56. Dev. Biol. (Basel) JC De Jong 115 63 2003 De Jong, J. C. et al. Haemagglutination-inhibiting antibody to influenza virus. Dev. Biol. (Basel) 115, 63-73 (2003). 

57. J. Rheumatol. A Chalmers 21 1203 1994 Chalmers, A. et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J. Rheumatol. 21, 1203-1206 (1994). 

    상세보기

58. Vaccine F Del Porto 24 3217 2006 10.1016/j.vaccine.2006.01.028 Del Porto, F. et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 24, 3217-3223 (2006). 

    상세보기

59. Ann. Rheum. Dis. EJ Denman 29 220 1970 10.1136/ard.29.3.220 Denman, E. J., Denman, A. M., Greenwood, B. M., Gall, D. & Heath, R. B. Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann. Rheum. Dis. 29, 220-231 (1970). 

    상세보기

60. Ann. Rheum. Dis. I Fomin 65 191 2006 10.1136/ard.2005.036434 Fomin, I. et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF α blockers. Ann. Rheum. Dis. 65, 191-194 (2006). 

    상세보기

61. Ann. Rheum. Dis. LB Gelinck 67 713 2008 10.1136/ard.2007.077552 Gelinck, L. B. et al. The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination. Ann. Rheum. Dis. 67, 713-716 (2008). 

    상세보기

62. JAMA A Herron 242 53 1979 10.1001/jama.1979.03300010037025 Herron, A. et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 242, 53-56 (1979). 

    상세보기

63. J. Rheumatol. JL Kaine 34 272 2007 Kaine, J. L., Kivitz, A. J., Birbara, C. & Luo, A. Y. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J. Rheumatol. 34, 272-279 (2007). 

    상세보기

64. Mod. Rheumatol. T Kubota 17 531 2007 10.3109/s10165-007-0632-5 Kubota, T. et al. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 17, 531-533 (2007). 

    상세보기

65. Mod. Rheumatol. T Nii 19 216 2009 10.3109/s10165-008-0135-z Nii, T. et al. Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers. Mod. Rheumatol. 19, 216-218 (2009). 

    상세보기

66. Ann. Rheum. Dis. L Turner-Stokes 47 532 1988 10.1136/ard.47.7.532 Turner-Stokes, L., Cambridge, G., Corcoran, T., Oxford, J. S. & Snaith, M. L. In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann. Rheum. Dis. 47, 532-535 (1988). 

    상세보기

67. Arthritis Rheum. S Van Assen 62 75 2010 10.1002/art.25033 Van Assen, S. et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum. 62, 75-81 (2010). 

    상세보기

68. Clin. Dev. Immunol. O Elkayam 13 349 2006 10.1080/17402520600589613 Elkayam, O. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Clin. Dev. Immunol. 13, 349-351 (2006). 

    상세보기

69. Rheumatology (Oxford) MC Kapetanovic 46 608 2007 10.1093/rheumatology/kel366 Kapetanovic, M. C., Saxne, T., Nilsson, J. A. & Geborek, P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46, 608-611 (2007). 

    상세보기

70. J. Rheumatol. AJ Kivitz 41 648 2014 10.3899/jrheum.130945 Kivitz, A. J. et al. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial. J. Rheumatol. 41, 648-657 (2014). 

    상세보기

71. Semin. Arthritis Rheum. O Elkayam 39 442 2010 10.1016/j.semarthrit.2008.12.002 Elkayam, O. et al. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum. 39, 442-447 (2010). 

    상세보기

72. Ann. Rheum. Dis. LB Gelinck 66 1402 2007 10.1136/ard.2007.071878 Gelinck, L. B. et al. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann. Rheum. Dis. 66, 1402-1403 (2007). 

    상세보기

73. J. Rheumatol. MC Kapetanovic 41 626 2014 10.3899/jrheum.140063 Kapetanovic, M. C. Further evidence for influenza and pneumococcal vaccination in patients treated with disease modifying antirheumatic drugs and anti-tumor necrosis factor agents. J. Rheumatol. 41, 626-628 (2014). 

    상세보기

74. Arthritis Res. Ther. MC Kapetanovic 16 R2 2014 10.1186/ar4427 Kapetanovic, M. C. et al. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis. Arthritis Res. Ther. 16, R2 (2014). 

    상세보기

75. Ann. Rheum. Dis. S Oren 67 937 2008 10.1136/ard.2007.077461 Oren, S. et al. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann. Rheum. Dis. 67, 937-941 (2008). 

    상세보기

76. Arthritis Care Res. (Hoboken) O Elkayam 63 1062 2011 10.1002/acr.20465 Elkayam, O. et al. Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res. (Hoboken) 63, 1062-1067 (2011). 

    상세보기

77. Ann. Rheum. Dis. S Mori 71 2006 2012 10.1136/annrheumdis-2012-201950 Mori, S. et al. Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann. Rheum. Dis. 71, 2006-2010 (2012). 

    상세보기

78. Arthritis Care Res. (Hoboken) AC Ribeiro 65 476 2013 10.1002/acr.21838 Ribeiro, A. C. et al. Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis Care Res. (Hoboken) 65, 476-480 (2013). 

    상세보기

79. Ann. Intern. Med. GW Williams 88 729 1978 10.7326/0003-4819-88-6-729 Williams, G. W. et al. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann. Intern. Med. 88, 729-734 (1978). 

    상세보기

80. Ann. Rheum. Dis. A Holvast 65 913 2006 10.1136/ard.2005.043943 Holvast, A. et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann. Rheum. Dis. 65, 913-918 (2006). 

    상세보기

81. Rev. Invest. Clin. U Mercado 56 16 2004 Mercado, U., Acosta, H. & Avendano, L. Influenza vaccination of patients with systemic lupus erythematosus. Rev. Invest. Clin. 56, 16-20 (2004). 

82. Clin. Rheumatol. E Wiesik-Szewczyk 29 605 2010 10.1007/s10067-010-1373-y Wiesik-Szewczyk, E. et al. Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. Clin. Rheumatol. 29, 605-613 (2010). 

    상세보기

83. Ann. Intern. Med. R Brodman 88 735 1978 10.7326/0003-4819-88-6-735 Brodman, R., Gilfillan, R., Glass, D. & Schur, P. H. Influenzal vaccine response in systemic lupus erythematosus. Ann. Intern. Med. 88, 735-740 (1978). 

    상세보기

84. Ann. Intern. Med. JS Louie 88 790 1978 10.7326/0003-4819-88-6-790 Louie, J. S. et al. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann. Intern. Med. 88, 790-792 (1978). 

    상세보기

85. J. Med. Virol. VG Pons 4 15 1979 10.1002/jmv.1890040103 Pons, V. G., Reinertsen, J. L., Steinberg, A. D. & Dolin, R. Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus. J. Med. Virol. 4, 15-23 (1979). 

    상세보기

86. Ann. Intern. Med. SC Ristow 88 786 1978 10.7326/0003-4819-88-6-786 Ristow, S. C., Douglas, R. G. Jr & Condemi, J. J. Influenza vaccination of patients with systemic lupus erythematosus. Ann. Intern. Med. 88, 786-789 (1978). 

    상세보기

87. J. Rheumatol. M Abu-Shakra 29 2555 2002 Abu-Shakra, M. et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J. Rheumatol. 29, 2555-2557 (2002). 

    상세보기

88. Arthritis Rheum. SR Crowe 63 2396 2011 10.1002/art.30388 Crowe, S. R. et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 63, 2396-2406 (2011). 

    상세보기

89. Rheumatology (Oxford) A Holvast 48 1294 2009 10.1093/rheumatology/kep200 Holvast, A. et al. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Rheumatology (Oxford) 48, 1294-1299 (2009). 

    상세보기

90. Ann. Rheum. Dis. A Holvast 68 873 2009 10.1136/ard.2008.092924 Holvast, A. et al. Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Ann. Rheum. Dis. 68, 873-878 (2009). 

    상세보기

91. J. Physiol. Pharmacol. K Zycinska 58 Suppl. 5 819 2007 Zycinska, K. et al. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. J. Physiol. Pharmacol. 58 (Suppl. 5), 819-828 (2007). 

92. Vaccine M Setti 27 3367 2009 10.1016/j.vaccine.2009.01.078 Setti, M. et al. Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients. Vaccine 27, 3367-3372 (2009). 

    상세보기

93. Ann. Rheum. Dis. CG Saad 70 1068 2011 10.1136/ard.2011.150250 Saad, C. G. et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann. Rheum. Dis. 70, 1068-1073 (2011). 

    상세보기

94. Arthritis Rheum. C Gabay 63 1486 2011 10.1002/art.30325 Gabay, C. et al. Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum. 63, 1486-1496 (2011). 

    상세보기

95. Rheumatol. Int. M Iwamoto 32 3691 2012 10.1007/s00296-011-2118-1 Iwamoto, M. et al. Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season. Rheumatol. Int. 32, 3691-3694 (2012). 

    상세보기

96. Arthritis Rheum. A Mathian 63 3502 2011 10.1002/art.30576 Mathian, A. et al. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. Arthritis Rheum. 63, 3502-3511 (2011). 

    상세보기

97. Vaccine CC Lu 29 444 2011 10.1016/j.vaccine.2010.10.081 Lu, C. C. et al. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 29, 444-450 (2011). 

    상세보기

98. Vaccine SG Pasoto 31 1793 2013 10.1016/j.vaccine.2013.01.057 Pasoto, S. G. et al. Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome. Vaccine 31, 1793-1798 (2013). 

    상세보기

99. Vaccine U Arad 29 1643 2011 10.1016/j.vaccine.2010.12.072 Arad, U. et al. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine 29, 1643-1648 (2011). 

    상세보기

100. Arthritis Rheum. A Holvast 60 2438 2009 10.1002/art.24679 Holvast, A. et al. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum. 60, 2438-2447 (2009). 

     상세보기

101. Ann. Rheum. Dis. E Coulson 70 1289 2011 10.1136/ard.2010.144451 Coulson, E. et al. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate. Ann. Rheum. Dis. 70, 1289-1291 (2011). 

     상세보기

102. J. Rheumatol. S Visvanathan 34 952 2007 Visvanathan, S., Keenan, G. F., Baker, D. G., Levinson, A. I. & Wagner, C. L. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J. Rheumatol. 34, 952-957 (2007). 

     상세보기

103. Rheumatology (Oxford) MC Kapetanovic 45 106 2006 10.1093/rheumatology/kei193 Kapetanovic, M. C. et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45, 106-111 (2006). 

     상세보기

104. Arthritis Rheum. CO Bingham 3rd 62 64 2010 10.1002/art.25034 Bingham, C. O. 3rd et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum. 62, 64-74 (2010). 

     상세보기

105. Clin. Infect. Dis. O Elkayam 34 147 2002 10.1086/338043 Elkayam, O. et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin. Infect. Dis. 34, 147-153 (2002). 

     상세보기

106. Semin. Arthritis Rheum. O Elkayam 33 283 2004 10.1053/j.semarthrit.2003.10.003 Elkayam, O., Caspi, D., Reitblatt, T., Charboneau, D. & Rubins, J. B. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin. Arthritis Rheum. 33, 283-288 (2004). 

     상세보기

107. Arthritis Rheum. MC Kapetanovic 63 3723 2011 10.1002/art.30580 Kapetanovic, M. C. et al. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis Rheum. 63, 3723-3732 (2011). 

     상세보기

108. Clin. Rheumatol. MC Kapetanovic 30 1555 2011 10.1007/s10067-011-1856-5 Kapetanovic, M. C., Roseman, C., Jönsson, G. & Truedsson, L. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs. Clin. Rheumatol. 30, 1555-1561 (2011). 

     상세보기

109. Ann. Rheum. Dis. S Mori 72 1362 2013 10.1136/annrheumdis-2012-202658 Mori, S. et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann. Rheum. Dis. 72, 1362-1366 (2013). 

     상세보기

110. 10.1136/annrheumdis-2013-204427 Bingham, C. O. 3rd et al. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204427 . 

     상세보기

111. J. Rheumatol. SM Croft 11 141 1984 Croft, S. M. et al. Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. J. Rheumatol. 11, 141-146 (1984). 

     상세보기

112. J. Rheumatol. RN Lipnick 12 1118 1985 Lipnick, R. N. et al. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J. Rheumatol. 12, 1118-1121 (1985). 

     상세보기

113. Arthritis Rheum. DF Battafarano 41 1828 1998 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.0.CO;2-T Battafarano, D. F. et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 41, 1828-1834 (1998). 

     상세보기

114. Arthritis Rheum. MP Jarrett 23 1287 1980 10.1002/art.1780231110 Jarrett, M. P., Schiffman, G., Barland, P. & Grayzel, A. I. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum. 23, 1287-1293 (1980). 

     상세보기

115. J. Rheumatol. E McDonald 11 306 1984 McDonald, E., Jarrett, M. P., Schiffman, G. & Grayzel, A. I. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J. Rheumatol. 11, 306-308 (1984). 

     상세보기

116. Scand. J. Rheumatol. P Tarjan 31 211 2002 10.1080/030097402320318396 Tarjan, P. et al. No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 31, 211-215 (2002). 

     상세보기

117. Ann. Rheum. Dis. G Franco Salinas 68 Suppl. 3 238 2009 Franco Salinas, G. et al. TNF blockade impairs T cell dependent antibody responses [abstract]. Ann. Rheum. Dis. 68 (Suppl. 3), 238 (2009). 

118. J. Rheumatol. PJ Mease 31 1356 2004 Mease, P. J. et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J. Rheumatol. 31, 1356-1361 (2004). 

     상세보기

119. J. Rheumatol. U Mercado 36 1549 2009 10.3899/jrheum.081227 Mercado, U., Acosta, H. & Diaz-Molina, R. Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis. J. Rheumatol. 36, 1549-1550 (2009). 

     상세보기

120. Lupus KA Kuruma 16 350 2007 10.1177/0961203307078225 Kuruma, K. A., Borba, E. F., Lopes, M. H., de Carvalho, J. F. & Bonfá, E. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16, 350-354 (2007). 

     상세보기

121. J. Gastroenterol. Hepatol. E Erkek 20 1508 2005 10.1111/j.1440-1746.2005.03903.x Erkek, E., Ayaslioglu, E., Erkek, A. B., Kurtipek, G. S. & Bagci, Y. Response to vaccination against hepatitis B in patients with Behcet's disease. J. Gastroenterol. Hepatol. 20, 1508-1511 (2005). 

     상세보기

122. Clin. Exp. Immunol. ME Devey 68 562 1987 Devey, M. E., Bleasdale, K. & Isenberg, D. A. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 68, 562-569 (1987). 

     상세보기

123. Acta Rheumatol. Scand. T Abe 17 35 1971 10.3109/rhe1.1971.17.issue-1-4.06 Abe, T. & Homma, M. Immunological reactivity in patients with systemic lupus erythematosus. Humoral antibody and cellular immune responses. Acta Rheumatol. Scand. 17, 35-46 (1971). 

     상세보기

124. Iran. J. Immunol. S Kashef 5 181 2008 Kashef, S., Ghazizadeh, F., Derakhshan, A., Farjadian, S. & Alyasin, S. Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran. J. Immunol. 5, 181-184 (2008). 

125. Arthritis Rheum. K Nies 23 1343 1980 10.1002/art.1780231203 Nies, K., Boyer, R., Stevens, R. & Louie, J. Anti-tetanus toxoid antibody synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo responses. Arthritis Rheum. 23, 1343-1350 (1980). 

     상세보기

126. Travel Med. Infect. Dis. HH Askling 12 134 2014 10.1016/j.tmaid.2014.01.005 Askling, H. H. et al. Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study. Travel Med. Infect. Dis. 12, 134-142 (2014). 

     상세보기

127. Ann. Rheum. Dis. CC Mok 72 659 2013 10.1136/annrheumdis-2012-201393 Mok, C. C., Ho, L. Y., Fong, L. S. & To, C. H. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann. Rheum. Dis. 72, 659-664 (2013). 

     상세보기

128. Pediatr. Rheumatol. Online J. A Soybilgic 11 29 2013 10.1186/1546-0096-11-29 Soybilgic, A., Onel, K. B., Utset, T., Alexander, K. & Wagner-Weiner, L. Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12 to 26 years. Pediatr. Rheumatol. Online J. 11, 29 (2013). 

     상세보기

129. Ann. Rheum. Dis. S Van Assen 70 414 2011 10.1136/ard.2010.137216 Van Assen, S. et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis. 70, 414-422 (2011). 

     상세보기

130. Arthritis Care. Res. (Hoboken) JA Singh 64 625 2012 10.1002/acr.21641 Singh, J. A. et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care. Res. (Hoboken) 64, 625-639 (2012). 

     상세보기

131. JAMA J Zhang 308 43 2012 Zhang, J. et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 308, 43-49 (2012). 

     상세보기

132. J. Rheumatol. JM Guthridge 40 1875 2013 10.3899/jrheum.130170 Guthridge, J. M. et al. Herpes zoster vaccination in SLE: a pilot study of immunogenicity. J. Rheumatol. 40, 1875-1880 (2013). 

     상세보기

133. J. Autoimmun. Y Shoenfeld 36 4 2011 10.1016/j.jaut.2010.07.003 Shoenfeld, Y. & Agmon-Levin, N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J. Autoimmun. 36, 4-8 (2011). 

     상세보기

134. J. Autoimmun. S Colafrancesco 51 10 2014 10.1016/j.jaut.2014.03.003 Colafrancesco, S., Perricone, C., Priori, R., Valesini, G. & Shoenfeld, Y. Sjögren's syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J. Autoimmun. 51, 10-16 (2014). 

     상세보기

135. J. Autoimmun. C Perricone 47 1 2013 10.1016/j.jaut.2013.10.004 Perricone, C. et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J. Autoimmun. 47, 1-16 (2013). 

     상세보기

136. J. Investig. Allergol. Clin. Immunol. AT Borchers 12 155 2002 Borchers, A. T., Keen, C. L., Shoenfeld, Y., Silva, J. Jr & Gershwin, M. E. Vaccines, viruses, and voodoo. J. Investig. Allergol. Clin. Immunol. 12, 155-168 (2002). 

     상세보기

137. Ann. Rheum. Dis. C Bengtsson 69 1831 2010 10.1136/ard.2010.129908 Bengtsson, C. et al. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann. Rheum. Dis. 69, 1831-1833 (2010). 

     상세보기

138. Arthritis Rheumatol. L Grimaldi-Bensouda 66 1559 2014 10.1002/art.38429 Grimaldi-Bensouda, L. et al. The risk of systemic lupus erythematosus associated with vaccines: an international case-control study. Arthritis Rheumatol. 66, 1559-1567 (2014). 

     상세보기

139. Lupus K Perdan-Pirkmajer 21 175 2012 10.1177/0961203311429817 Perdan-Pirkmajer, K. et al. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus 21, 175-183 (2012). 

     상세보기

140. Vaccine CC Lu 29 444 2011 10.1016/j.vaccine.2010.10.081 Lu, C. C. et al. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity. Vaccine 29, 444-450 (2011). 

     상세보기

141. Arthritis Care Res. (Hoboken) MB Urowitz 63 1517 2011 10.1002/acr.20599 Urowitz, M. B., Anton, A., Ibanez, D. & Gladman, D. D. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care Res. (Hoboken) 63, 1517-1520 (2011). 

     상세보기

142. Clin. Exp. Immunol. F Milanetti 177 287 2014 10.1111/cei.12292 Milanetti, F. et al. Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals. Clin. Exp. Immunol. 177, 287-294 (2014). 

     상세보기

143. Scand. J. Rheumatol. NE Aikawa 42 34 2013 10.3109/03009742.2012.709272 Aikawa, N. E. et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scand. J. Rheumatol. 42, 34-40 (2013). 

     상세보기

144. Nephrol. Dial. Transplant. PM Stassen 23 654 2008 10.1093/ndt/gfm640 Stassen, P. M., Sanders, J. S., Kallenberg, C. G. & Stegeman, C. A. Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 23, 654-658 (2008). 

     상세보기

145. Arthritis Rheum. J Karsh 23 1294 1980 10.1002/art.1780231111 Karsh, J., Pavlidis, N., Schiffman, G. & Moutsopoulos, H. M. Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Arthritis Rheum. 23, 1294-1298 (1980). 

     상세보기

146. J. Intern. Med. L Grimaldi-Bensouda 275 398 2014 10.1111/joim.12155 Grimaldi-Bensouda, L. et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J. Intern. Med. 275, 398-408 (2014). 

     상세보기

147. Clin. Rheumatol. M Gatto 32 1301 2013 10.1007/s10067-013-2266-7 Gatto, M. et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin. Rheumatol. 32, 1301-1307 (2013). 

     상세보기

148. Lupus HF Soldevilla 21 158 2012 10.1177/0961203311429556 Soldevilla, H. F., Briones, S. F. & Navarra, S. V. Systemic lupus erythematosus following HPV immunization or infection? Lupus 21, 158-161 (2012). 

     상세보기

149. Arthritis Res. Ther. J Zhang 13 R174 2011 10.1186/ar3497 Zhang, J. et al. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study. Arthritis Res. Ther. 13, R174 (2011). 

     상세보기

150. Ann. Rheum. Dis. MW Heijstek 70 1704 2011 10.1136/ard.2011.150193 Heijstek, M. W. et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann. Rheum. Dis. 70, 1704-1712 (2011). 

     상세보기

151. Ann. Rheum. Dis. JB Galloway 72 229 2013 10.1136/annrheumdis-2011-201108 Galloway, J. B. et al. Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Ann. Rheum. Dis. 72, 229-234 (2013). 

     상세보기

152. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) [online] , (2011). 

153. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) [online] , (2011).